| Literature DB >> 30011114 |
Inés García-Consuegra1,2, Sara Asensio-Peña1, Alfonsina Ballester-Lopez2,3, Rosario Francisco-Velilla4, Tomás Pinos2,5, Guillem Pintos-Morell2,3,6, Jaume Coll-Cantí2,3,7, Adrián González-Quintana1, Antoni L Andreu2,5, Joaquín Arenas1,2, Alejandro Lucia8, Gisela Nogales-Gadea2,3, Miguel A Martín1,2.
Abstract
McArdle disease is a disorder of muscle glycogen metabolism caused by mutations in the PYGM gene, encoding for the muscle-specific isoform of glycogen phosphorylase (M-GP). The activity of this enzyme is completely lost in patients' muscle biopsies, when measured with a standard biochemical test which, does not allow to determine M-GP protein levels. We aimed to determine M-GP protein levels in the muscle of McArdle patients, by studying biopsies of 40 patients harboring a broad spectrum of PYGM mutations and 22 controls. Lack of M-GP protein was found in muscle in the vast majority (95%) of patients, irrespective of the PYGM genotype, including those carrying missense mutations, with few exceptions. M-GP protein biosynthesis is not being produced by PYGM mutations inducing premature termination codons (PTC), neither by most PYGM missense mutations. These findings explain the lack of PYGM genotype-phenotype correlation and have important implications for the design of molecular-based therapeutic approaches.Entities:
Keywords: McArdle disease; genotype-phenotype correlation; missense mutations; muscle glycogen phosphorylase
Mesh:
Substances:
Year: 2018 PMID: 30011114 DOI: 10.1002/humu.23591
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878